NEXICLON Trademark

Trademark Overview

On Tuesday, October 29, 2019, a trademark application was filed for NEXICLON with the United States Patent and Trademark Office. The USPTO has given the NEXICLON trademark a serial number of 88672961. The federal status of this trademark filing is REGISTERED as of Tuesday, November 1, 2022. This trademark is owned by TRIS PHARMA, INC. The NEXICLON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, intended for the treatment of various indications, including, hypertension, Tourette's Syndrome, Attention Deficient Hyperactivity Disorder and Autism
nexiclon

General Information

Serial Number88672961
Word MarkNEXICLON
Filing DateTuesday, October 29, 2019
Status700 - REGISTERED
Status DateTuesday, November 1, 2022
Registration Number6890002
Registration DateTuesday, November 1, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, intended for the treatment of various indications, including, hypertension, Tourette's Syndrome, Attention Deficient Hyperactivity Disorder and Autism

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 2, 2019
Primary Code005
First Use Anywhere DateSaturday, July 31, 2021
First Use In Commerce DateSaturday, July 31, 2021

Trademark Owner History

Party NameTRIS PHARMA, INC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
Party NameTRIS PHARMA, INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
Party NameTRIS PHARMA, INC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852

Trademark Events

Event DateEvent Description
Tuesday, November 1, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 1, 2022REGISTERED-PRINCIPAL REGISTER
Friday, September 30, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 29, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 29, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 15, 2022USE AMENDMENT FILED
Thursday, September 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 15, 2022TEAS STATEMENT OF USE RECEIVED
Friday, April 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 27, 2022SOU EXTENSION 4 GRANTED
Wednesday, April 27, 2022SOU EXTENSION 4 FILED
Wednesday, April 27, 2022TEAS EXTENSION RECEIVED
Monday, January 3, 2022ASSIGNED TO EXAMINER
Saturday, November 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 4, 2021SOU EXTENSION 3 GRANTED
Thursday, November 4, 2021SOU EXTENSION 3 FILED
Thursday, November 4, 2021TEAS EXTENSION RECEIVED
Tuesday, May 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 2, 2021SOU EXTENSION 2 GRANTED
Sunday, May 2, 2021SOU EXTENSION 2 FILED
Sunday, May 2, 2021TEAS EXTENSION RECEIVED
Saturday, November 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 5, 2020SOU EXTENSION 1 GRANTED
Thursday, November 5, 2020SOU EXTENSION 1 FILED
Thursday, November 5, 2020TEAS EXTENSION RECEIVED
Tuesday, May 5, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 3, 2020ASSIGNED TO EXAMINER
Saturday, November 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 1, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

nexiclon preparations pharmaceutical syndrome tourette attention hyperactivity autism disorder hypertension deficient